ci 966 has been researched along with no 711 in 1 studies
Studies (ci 966) | Trials (ci 966) | Recent Studies (post-2010) (ci 966) | Studies (no 711) | Trials (no 711) | Recent Studies (post-2010) (no 711) |
---|---|---|---|---|---|
14 | 0 | 4 | 20 | 0 | 15 |
Protein | Taxonomy | ci 966 (IC50) | no 711 (IC50) |
---|---|---|---|
Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | 0.1111 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borden, LA; Branchek, TA; Gluchowski, C; Murali Dhar, TG; Smith, KE; Weinshank, RL | 1 |
1 other study(ies) available for ci 966 and no 711
Article | Year |
---|---|
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
Topics: Animals; Anticonvulsants; Carrier Proteins; Cell Line; Cloning, Molecular; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nicotinic Acids; Nipecotic Acids; Organic Anion Transporters; Oximes; Pyridines; Rats; Recombinant Proteins; Structure-Activity Relationship; Tiagabine; Transfection | 1994 |